Victory Capital Management Inc Seelos Therapeutics, Inc. Transaction History

Victory Capital Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$0.16 - $1.64 $102 - $1,049	640 Added 4.95%	13,577 $2,000
Q2 2023 Jul 27, 2023	BUY	$0.66 - $1.22 $852 - $1,575	1,291 Added 11.09%	12,937 $15,000
Q1 2023 May 02, 2023	SELL	$0.59 - $1.04 $58 - $102	-99 Reduced 0.84%	11,646 $8,000
Q4 2022 Feb 09, 2023	SELL	$0.66 - $259.46 $2 - $1,037	-4 Reduced 0.03%	11,745 $7,000
Q3 2022 Nov 02, 2022	SELL	$0.65 - $278.68 $1,469 - $630,095	-2,261 Reduced 16.14%	11,749 $12,000
Q2 2022 Aug 01, 2022	BUY	$0.51 - $0.93 $201 - $368	396 Added 2.91%	14,010 $10,000
Q1 2022 May 04, 2022	SELL	$0.84 - $1.71 $620 - $1,263	-739 Reduced 5.15%	13,614 $8,000
Q4 2021 Feb 07, 2022	SELL	$1.59 - $2.38 $849 - $1,270	-534 Reduced 3.59%	14,353 $23,000
Q3 2021 Nov 02, 2021	SELL	$1.69 - $2.89 $888 - $1,520	-526 Reduced 3.41%	14,887 $36,000
Q2 2021 Aug 03, 2021	BUY	$2.64 - $6.32 $12,257 - $29,343	4,643 Added 43.11%	15,413 $41,000
Q1 2021 May 04, 2021	BUY	$1.35 - $4.99 $14,539 - $53,742	10,770 New	10,770 $54,000
Q2 2020 Aug 07, 2020	SELL	$0.42 - $1.51 $2,829 - $10,174	-6,738 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$0.47 - $1.56 $1,349 - $4,478	2,871 Added 74.24%	6,738 $3,000
Q4 2019 Feb 04, 2020	BUY	$0.72 - $1.52 $704 - $1,486	978 Added 33.85%	3,867 $4,000
Q3 2019 Nov 12, 2019	BUY	$0.92 - $2.15 $2,657 - $6,211	2,889 New	2,889 $3,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.